July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
AI in ophthalmology: commercial considerations
Author Affiliations & Notes
  • Carlos Ciller
    Advanced Imaging Group, RetinAI Medical AG, Bern, Bern, Switzerland
  • Footnotes
    Commercial Relationships   Carlos Ciller, RetinAI Medical AG (E), RetinAI Medical AG (I)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1410. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Carlos Ciller; AI in ophthalmology: commercial considerations. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1410.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Presentation Description : Over the past few years AI is gradually having a larger impact in the world of ophthalmic care. Specially relevant is the contribution to supporting eye care professional during the process of decision making, or even for the optimization of current existing clinical workflows. This presentation will cover latest developments in AI for the most common age-related eye diseases, how these conditions can be better monitored using AI technologies available in the market and the impact that these new trends will have in clinical protocols of the future.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.